A 5-Year Longitudinal, Multicentre Validation Study Assessing the Prognostic Value of Plasma Fibronectin in a Cohort of Parkinson's Disease ParticipantsShuzhen Zhu, Zhenchao Xie, Shujuan Yang et al.|SSRN Electronic Journal|2023Cited by 0